title: Primary human hepatocytes on biodegradable poly(l-lactic acid) matrices: a promising model for improving transplantation efficiency with tissue engineering.
abstract: Liver transplantation is an established treatment for acute and chronic liver disease. However, because of the shortage of donor organs, it does not fulfill the needs of all patients. Hepatocyte transplantation is promising as an alternative method for the treatment of end-stage liver disease and as bridging therapy until liver transplantation. Our group has been working on the optimization of matrix-based hepatocyte transplantation. In order to increase cell survival after transplantation, freshly isolated human hepatocytes were seeded onto biodegradable poly(l-lactic acid) (PLLA) polymer scaffolds and were cultured in a flow bioreactor. PLLA discs were seeded with human hepatocytes and exposed to a recirculated medium flow for 6 days. Human hepatocytes formed spheroidal aggregates with a liver-like morphology and active metabolic function. Phase contrast microscopy showed increasing numbers of spheroids of increasing diameter during the culture period. Hematoxylin and eosin histology showed viable and intact hepatocytes inside the spheroids. Immunohistochemistry confirmed sustained hepatocyte function and a preserved hepatocyte-specific cytoskeleton. Albumin, alpha-1-antitrypsin, and urea assays showed continued production during the culture period. Northern blot analysis demonstrated increasing albumin signals. Scanning electron micrographs showed hepatocyte spheroids with relatively smooth undulating surfaces and numerous microvilli. Transmission electron micrographs revealed intact hepatocytes and junctional complexes with coated pits and vesicles inside the spheroids. Therefore, we conclude that primary human hepatocytes, precultured in a flow bioreactor on a PLLA scaffold, reorganize to form morphologically intact liver neotissue, and this might offer an optimized method for hepatocyte transplantation because of the expected reduction of the initial cell loss, the high regenerative potential in vivo, and the preformed functional integrity.
authors.affiliation: Departments of Hepatobiliary and Transplant Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
authors.forename: Eva
authors.initials: E
authors.lastname: Török
authors.forename: Marc
authors.initials: M
authors.lastname: Lutgehetmann
authors.forename: Jeanette
authors.initials: J
authors.lastname: Bierwolf
authors.forename: Stefan
authors.initials: S
authors.lastname: Melbeck
authors.forename: Jochen
authors.initials: J
authors.lastname: Düllmann
authors.forename: Bjoern
authors.initials: B
authors.lastname: Nashan
authors.forename: Peter X
authors.initials: PX
authors.lastname: Ma
authors.forename: Joerg M
authors.initials: JM
authors.lastname: Pollok
mesh_terms: D020341:Absorbable Implants; D015415:Biomarkers / Q000378:metabolism; D019149:Bioreactors; D015152:Blotting, Northern; D002469:Cell Separation; D048430:Cell Shape; D002470:Cell Survival; D002478:Cells, Cultured; D005455:Fluorescent Antibody Technique; D022781:Hepatocytes / Q000378:metabolism / Q000637:transplantation* / Q000648:ultrastructure; D006801:Humans; D007150:Immunohistochemistry; D019344:Lactic Acid; D008115:Liver Regeneration; D008855:Microscopy, Electron, Scanning; D046529:Microscopy, Electron, Transmission; D011091:Polyesters; D011108:Polymers; D012709:Serum Albumin / Q000235:genetics / Q000378:metabolism; D013997:Time Factors; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds; D014508:Urea / Q000378:metabolism; D000515:alpha 1-Antitrypsin / Q000378:metabolism
chemical_list: D015415:Biomarkers; D011091:Polyesters; D011108:Polymers; D012709:Serum Albumin; D000515:alpha 1-Antitrypsin; D019344:Lactic Acid; C033616:poly(lactide); D014508:Urea